BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$4.10 +0.18 (+4.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Preferred Stock Liabilities (2024 - 2025)

Updated

BridgeBio Oncology Therapeutics (BBOT) posted Preferred Stock Liabilities of $196.51 million for Q2 2025, up 4.7% from $187.65 million a year earlier and up 1.1% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends

At the end of FY2024, BridgeBio Oncology Therapeutics' Preferred Stock Liabilities came in at $192.45 million.

  • According to Business Quant data, Preferred Stock Liabilities for the three prior quarters was $194.44 million (Q1 2025), $192.45 million (Q4 2024) and $190.2 million (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 BridgeBio Oncology Therapeutics 328.47 Mn -1.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 196.51 Mn
Mar 31, 2025 194.44 Mn
Dec 31, 2024 192.45 Mn
Sep 30, 2024 190.20 Mn
Jun 30, 2024 187.65 Mn
Mar 31, 2024 185.21 Mn
API Access

BridgeBio Oncology Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BBOT&period=max&api_key=YOUR_API_KEY